Lingsuo Kong

475 total citations
18 papers, 289 citations indexed

About

Lingsuo Kong is a scholar working on Molecular Biology, Cancer Research and Surgery. According to data from OpenAlex, Lingsuo Kong has authored 18 papers receiving a total of 289 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 8 papers in Cancer Research and 5 papers in Surgery. Recurrent topics in Lingsuo Kong's work include RNA modifications and cancer (11 papers), Cancer-related molecular mechanisms research (6 papers) and Anesthesia and Pain Management (4 papers). Lingsuo Kong is often cited by papers focused on RNA modifications and cancer (11 papers), Cancer-related molecular mechanisms research (6 papers) and Anesthesia and Pain Management (4 papers). Lingsuo Kong collaborates with scholars based in China. Lingsuo Kong's co-authors include Zhenyu Li, Ran Wei, Zhen Duan, Fangfang Ge, Ruixiang Wang, Xingxing Zhu, Ying Liu, Fangfang Zhao, Youguang Pu and Qing Wei and has published in prestigious journals such as Acta Biomaterialia, Medicine and Journal of Cellular Biochemistry.

In The Last Decade

Lingsuo Kong

17 papers receiving 285 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lingsuo Kong China 9 149 108 48 41 29 18 289
Qiu Peng China 8 178 1.2× 87 0.8× 52 1.1× 29 0.7× 8 0.3× 12 315
Shiyu Meng China 8 156 1.0× 40 0.4× 94 2.0× 33 0.8× 18 0.6× 15 383
Cao Gao China 11 161 1.1× 122 1.1× 14 0.3× 27 0.7× 6 0.2× 19 326
Xinghua Jiang China 10 192 1.3× 129 1.2× 12 0.3× 41 1.0× 11 0.4× 22 335
Minli Sun China 11 92 0.6× 22 0.2× 22 0.5× 33 0.8× 49 1.7× 22 289
Yunliang Sun China 9 110 0.7× 37 0.3× 38 0.8× 57 1.4× 46 1.6× 16 287
J. J. Wang Taiwan 8 73 0.5× 22 0.2× 19 0.4× 86 2.1× 85 2.9× 12 315
Weifeng Yu China 10 95 0.6× 30 0.3× 7 0.1× 67 1.6× 13 0.4× 25 419
Xiaofeng Duan China 13 102 0.7× 35 0.3× 58 1.2× 63 1.5× 56 1.9× 41 458

Countries citing papers authored by Lingsuo Kong

Since Specialization
Citations

This map shows the geographic impact of Lingsuo Kong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lingsuo Kong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lingsuo Kong more than expected).

Fields of papers citing papers by Lingsuo Kong

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lingsuo Kong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lingsuo Kong. The network helps show where Lingsuo Kong may publish in the future.

Co-authorship network of co-authors of Lingsuo Kong

This figure shows the co-authorship network connecting the top 25 collaborators of Lingsuo Kong. A scholar is included among the top collaborators of Lingsuo Kong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lingsuo Kong. Lingsuo Kong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Shen, Tianjiao, et al.. (2025). Mediating role of pain sensitization in preoperative and postoperative pain in knee osteoarthritis patients. European journal of medical research. 30(1). 301–301.
2.
Wei, Ran, Fangfang Zhao, Lingsuo Kong, et al.. (2024). The antagonistic effect of FTO on METTL14 promotes AKT3 m6A demethylation and the progression of esophageal cancer. Journal of Cancer Research and Clinical Oncology. 150(3). 131–131. 1 indexed citations
3.
Wei, Ran, et al.. (2024). HIF-1A as a prognostic biomarker related to invasion, migration and immunosuppression of cervical cancer. Heliyon. 10(2). e24664–e24664. 11 indexed citations
4.
Zhou, Mengni, Ying Wang, Rong Zeng, et al.. (2024). Local anesthetic delivery systems for the management of postoperative pain. Acta Biomaterialia. 181. 1–18. 6 indexed citations
5.
Kong, Lingsuo, Fei Gao, Xia Ran, et al.. (2023). Profiling the m6A-regulated RNA expression patterns and alternative splicing features in esophageal carcinoma. Genes & Diseases. 10(5). 1812–1815. 3 indexed citations
6.
Zhao, Fangfang, Shuhan Liu, Chunbao Zang, et al.. (2022). A New Functional Gene, Zinc Finger Protein 485 (ZNF485), is Involved in Bladder Cancer Proliferation. Bladder Cancer. 8(2). 165–177. 1 indexed citations
8.
Li, Zhenyu, et al.. (2022). METTL3/m6A/IFIT2 regulates proliferation, invasion and immunity in esophageal squamous cell carcinoma. Frontiers in Pharmacology. 13. 1002565–1002565. 20 indexed citations
9.
Duan, Zhen, et al.. (2022). The significance of glycolysis in tumor progression and its relationship with the tumor microenvironment. Frontiers in Pharmacology. 13. 1091779–1091779. 94 indexed citations
10.
Zhao, Fangfang, Ming‐Hua Xie, Zhenyu Li, et al.. (2022). FTO mediated ERBB2 demethylation promotes tumor progression in esophageal squamous cell carcinoma cells. Clinical & Experimental Metastasis. 39(4). 623–639. 14 indexed citations
11.
Kong, Lingsuo, et al.. (2021). The DNA methylation-regulated MCTP1 activates the drug-resistance of esophageal cancer cells. Aging. 13(3). 3342–3352. 13 indexed citations
12.
Pu, Youguang, Chunbao Zang, Fangfang Zhao, et al.. (2021). LAMTOR5-AS1 regulates chemotherapy-induced oxidative stress by controlling the expression level and transcriptional activity of NRF2 in osteosarcoma cells. Cell Death and Disease. 12(12). 1125–1125. 25 indexed citations
13.
Kong, Lingsuo, Youguang Pu, Chunbao Zang, et al.. (2021). Long Noncoding RNA DICER1-AS1 Functions in Methylation Regulation on the Multi-Drugresistance of Osteosarcoma Cells via miR-34a-5p and GADD45A. Frontiers in Oncology. 11. 8 indexed citations
14.
Zeng, Rong, et al.. (2021). Establishment of predicting equation for individual sufentanil dosage postoperatively based on gene polymorphisms. Pain Practice. 22(1). 39–46. 3 indexed citations
15.
Yang, Wancai, Zhou Wang, Lingsuo Kong, et al.. (2020). Association between CD24 Ala/Val polymorphism and multiple sclerosis risk. Medicine. 99(15). e19530–e19530. 4 indexed citations
16.
Kong, Lingsuo, et al.. (2019). Ribosomal protein small subunit 15A (RPS15A) inhibits the apoptosis of breast cancer MDA‐MB‐231 cells via upregulating phosphorylated ERK1/2, Bad, and Chk1. Journal of Cellular Biochemistry. 121(1). 587–595. 5 indexed citations
17.
Kong, Lingsuo, et al.. (2019). Effect of dexmedetomidine on postoperative cognitive dysfunction and inflammation in patients after general anaesthesia. Medicine. 98(18). e15383–e15383. 56 indexed citations
18.
Kong, Lingsuo, et al.. (2019). miR-193a-3p Promotes Radio-Resistance of Nasopharyngeal Cancer Cells by Targeting SRSF2 Gene and Hypoxia Signaling Pathway. Medical science monitor basic research. 25. 53–62. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026